Exelixis
EXEL
#1580
Rank
C$15.62 B
Marketcap
$55.82
Share price
-0.36%
Change (1 day)
82.64%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company